SSRIs

Study of 15,000 people with depression: 1 in 5 experience ‘atypical’ type characterised by excessive sleep and weight gain, poorer response to common antidepressants (SSRIs), and generic risk for metabolic, inflammatory, and circadian (body clock) disturbances

History made: First ever research grants for PSSD, a long-term and underrecognized consequence of SSRIs

Study of 15,000 adults with depression: Night owls (evening types) report that SSRIs don’t work as well for them, compared to morning types